Tuberculosis biomarkers: From diagnosis to protection

133Citations
Citations of this article
392Readers
Mendeley users who have this article in their library.

Abstract

New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools for diagnosis and new biomarkers are required to evaluate both pathogen and host key elements of the response to infection. Non-sputum based diagnostic tests, biomarkers predictive of adequate responsiveness to treatment, and biomarkers of risk of developing active TB disease are major goals. Here, we review the current state of the field. Although reports on new candidate biomarkers are numerous, validation and independent confirmation are rare. Efforts are needed to reduce the gap between the exploratory up-stream identification of candidate biomarkers, and the validation of biomarkers against clear clinical endpoints in different populations. This will need a major commitment from both scientists and funding bodies.

Author supplied keywords

Cite

CITATION STYLE

APA

Goletti, D., Petruccioli, E., Joosten, S. A., & Ottenhoff, T. H. M. (2016). Tuberculosis biomarkers: From diagnosis to protection. Infectious Disease Reports, 8(2), 24–32. https://doi.org/10.4081/idr.2016.6568

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free